Cancer innovation has been a longstanding priority in the current administration. But sometimes overlooked is some of the nation’s most sophisticated lung cancer research underway at the Department of Veterans Affairs. This includes applying capacities like modernized electronic health records and artificial intelligence to support groundbreaking innovation. Dr. Michael Kelley, director of the National Precision Oncology Program, and Kenute Myrie, portfolio manager at the VA Office of Research and Development, discuss how the agency is advancing understanding of cancer and improving long-term health outcomes for veterans.
HealthCast
Season 3
Episode 24
27m listen
How VA is Leveraging Genomics and Big Data to Improve Lung Cancer Outcomes
Lung cancer innovation at the agency is looking at technology to improve detection and treatment.
-
Dr. Michael Kelley National Program Director for Oncology VA -
Dr. Kenute Myrie Lead for Precision Oncology, Office of Research and Development VA
Related Content
-
Trump's HHS Secretary Pick Eyes Transparency, Data Access
Nominee Robert Kennedy wants to improve transparency and data access to empower patients and enable innovation in health care technology.
4m read -
Federal Leaders Revamp Tech Workforce, Policy
Despite the rise in interest of emerging technology, federal leaders see data, policy and the workforce as a best vehicle for change.
4m read -
Labor CAIO Outlines Responsible and Ethical AI Priorities, Use Cases
Department of Labor Chief AI Officer Mangala Kuppa outlined how her role is shaping the agency’s artificial intelligence strategy.
20m watch -
Elevating Cybersecurity in the Intelligence Community
The Intelligence Community is developing strategies to protect data and strengthen resiliency against emerging cyber threats.
30m watch
